Fox Chase Cancer Center
To refer a patient call 888-FOX-CHASE (888-369-2427)
Temple Health
To refer a patient call 800-TEMPLE-MED (877-589-0013)
Featured Items |view more
Comprehensive Care That Empowers Patients Through Risk Management, Prevention, Detection, Treatment, and Survivorship Services
FEMALE PELVIC MEDICINE & RECONSTRUCTIVE SURGERY
Fox Chase – Temple Urologic Institute’s program is a comprehensive center serving women with pelvic floor disorders such as incontinence and pelvic order prolapse. Our team has extensive training and experience in the diagnosis and treatment ...
With one of the largest and most experienced urology teams in the region and the latest treatment capabilities, the Fox Chase-Temple Urologic Institute is a trusted regional leader in treating all types of urologic conditions. Our physicians ...
Researchers at Fox Chase Cancer Center and Lewis Katz School of Medicine at Temple University have identified factors that, if addressed, could decrease incidence of aggressive prostate cancer in areas where rates are highest — often Black ...
Tackling Anything Patients Need Before, During, and After Urologic Surgery
Growing up, Mary Ellen Day was athletic and focused—dreaming that one day, she would become a ‘real’ cheerleader.
Fox Chase Cancer Center Welcomes Dr. J. Ryan Mark
Fox Chase Cancer Center is pleased to announce the hiring of J. Ryan Mark, MD, FACS, as an Associate Professor in the Department of Urology at Fox Chase Cancer Center and a Fox Chase – Temple Urologic Institute provider.
ENDING THE RELIANCE ON BCG
A Phase III clinical trial for bladder cancer
The Phase III randomized trial compares Bacillus Calmette-Guerin (BCG) immunotherapy, the standard-of-care intravesical treatment for high grade non-muscle invasive bladder cancer, versus intravesical Docetaxel and Gemcitabine treatment in BCG naïve patients.
Fox Chase Cancer Center Opens First New Jersey Location in Voorhees
Fox Chase Cancer Center is proud to welcome patients to its newly opened office, which is located at 502 Centennial Boulevard, Suite 7, in Voorhees, New Jersey.
Integration, Location, Innovation: The Fox Chase-Temple Urologic Institute Leads the Way in Care
At Temple Health, we’re no stranger to firsts—whether that means performing a pioneering surgery, opening a new type of facility, or offering a groundbreaking treatment. That’s why it’s no surprise that we’re also leading the way in Urology ...
Fox Chase Researchers Examine Alternative Methods of Specialized Imaging Scans for Kidney Masses
In a study presented today at the American Urological Association (AUA) Annual Meeting 2024, researchers from Fox Chase Cancer Center showed that using numerical cutoffs as opposed to radiologist-read CT scans to determine whether a mass ...
In a study presented today at the American Urological Association (AUA) Annual Meeting 2024, researchers at Fox Chase Cancer Center showed that in men who have undergone surgery for prostate cancer, the function of artificial urinary sphincters ...
With one of the largest and most experienced urology teams in the region and the latest treatment capabilities, the Fox Chase-Temple Urologic Institute is a trusted leader in treating all types of urologic conditions.
Fox Chase-Temple Urologic Institute: The Next Generation of Urology Care
Our innovative partnership unites the expertise of distinguished institutions within one health system, allowing us to tackle the most challenging genitourinary malignancies as well as complex benign urologic conditions.
Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies
Join us for this in-person educational program, presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education. The program will cover the latest strategies for optimally managing localized and advanced ...
Nothing is lost in translation for Russian-speaking patients with urologic cancers
“Even when I was four, I wanted to be a clinician; I’d sit with my grandpa, listen to his ailments, and write prescriptions for him in Russian,” says Elena Dreyzin, PA-C., an advanced practice provider in the Fox Chase Cancer Center Department of Urology.
Study Investigates Hypomethylation Immunotherapy Combination in Bladder Cancer
Why does immunotherapy work for some bladder cancer patients and fail for others?
Fox Chase Cancer Center Study Challenges Assumptions About Cystic Renal Masses
A Fox Chase study ends up on the cover Journal of Urology cover by revealing a hidden danger in cystic renal masses.
Daniel Eun, MD, Fox Chase-Temple Urologic Institute Provider, discusses the potential benefits of robotic and minimally invasive surgery, and explains his goals for patients following robotic prostatectomy, including maintaining continence and sexual function.
Quality of Life Issues After Prostate Cancer
Michael Metro, MD, Fox Chase-Temple Urologic Institute Provider, discusses different interventions that can improve quality of life issues – such as erectile dysfunction and urinary incontinence -- for patients following prostate cancer surgery.
Daniel Eun, MD, Chief of Robotic Surgery at Temple University Hospital and Fox Chase-Temple Urologic Institute leader, discusses the different kidney sparing robotic and minimally invasive procedures available at Temple, and the potential ...
Temple Health Launches New Fox Chase-Temple Urologic Institute
Fox Chase Cancer Center and Temple Health are pleased to announce the new Fox Chase-Temple Urologic Institute, a groundbreaking initiative that will concentrate on both benign and oncologic urology.
Treatment for Urethral Stricture
Michael Metro, MD, Fox Chase-Temple Urologic Institute Provider, explains the symptoms and causes of urethral strictures -- a narrowing of the urethra, most typically within the area underneath the scrotum -- and how they are diagnosed and treated at Temple.
Aquablation: Changing the Surgical Landscape of BPH
Join Steve Sterious, MD FACS , Fox Chase-Temple Urologic Institute Provider, to discuss Aquablation and the changing surgical landscape of BPH.
Urinary Incontinence in Women: Evaluation and Management
Dr. Joshua Cohn, Fox Chase-Temple Urologic Institute Provider, discusses urinary incontinence in women, focusing on the etiology, prevalence and diagnostic evaluation. He also discusses the various treatment options that may be most helpful for each patient.
Centralizing scientific discovery, advanced research, and clinical care—all for a new therapeutic pathway.
Could NanoKnife be the future of prostate cancer care?
A Salvage Treatment Jennifer Was Inspired to Salvage.
A Life-Saving Idea for Bladder Cancer Patients.
Fox Chase Cancer Center Researchers Present Further Data on Potential Bladder-Sparing Treatment
Bladder removal is life-altering. This study examines when and why some patients may not need it.
Optimizing Treatment Strategies for Localized and Advanced Prostate Cancer
View this symposium presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education. Learn the most current strategies for optimally managing localized and advanced prostate cancer from the Fox Chase ...
Cancer Is a Moving Target.
CBCT-Based Adaptive Radiation Therapy Tracks It Every Day of Treatment.
Adaptive radiation therapy allows clinicians to make daily adjustments in a patient’s treatment in real time while the patient is on the treatment table based on the cancer’s response to the radiation, position of the tumor, and the location ...
The New Department of Urology at Fox Chase Cancer Center
Built on strength: world-class specialists, innovative researchers, and clinical leaders.
Dr. Laura Bukavina on the Front Lines of Research and War
Fighting for life everywhere she goes.
What is the Same and What Has Changed with the Artificial Urinary Sphincter?
The artificial urinary sphincter is an implantable device designed to treat incontinence in prostate cancer survivors. The device has existed for 50 years, and in that time, best practices around its use have undergone several paradigm shifts.
Fox Chase Urology Just Took a Big Leap Forward
A new benign urology team adds gravitas to a renowned cancer department.
Digging into the "why" of racial disparity in kidney cancer outcomes.
Exciting New Leadership for World-Class Growth
New appointments bring bold new ideas to genitourinary research and care.
Non-Oncologic Urologic Surgery
With a team that features national leaders in the field, Temple’s Robotic Urologic Surgery program is the gold standard in reconstructive surgery for patients who have experienced traumatic injury to the urinary tract, scarring from cancer ...
Peyronie’s Disease Presentation and Assessment
Michael J. Metro, MD, Fox Chase-Temple Urologic Institute Provider, discusses history, presentation and assessment of Peyronie’s Disease.
Transgender Health & Gender Affirming Surgery
Laura Douglass, MD (she/her), Fox Chase-Temple Urologic Institute Provider, discusses transgender health and gender affirming surgery. She discusses the importance of transgender and nonbinary health and how to provide gender affirming ...
Buccal Mucosa Graft Ureteroplasty: Technical Pointers
Daniel Eun, MD, Fox Chase-Temple Urologic Institute Provider, provides an overview of buccal mucosa graft ureteroplasty procedure and pointers for providers looking to learn how to perfom.
Pelvic Lymphoceles: Tips & Tricks to Avoid and Manage Them
Complications post surgery can include the development of pelvic lymphoceles which patients may present infection or external leaks. Daniel Eun, MD, Fox Chase-Temple Urologic Institute Provider, discusses how to avoid and manage lymphoceles ...
Robotic Assisted Laparoscopic Left Ileal Ureter Interposition for Long Segment Ureteral Stricture
Daniel Eun, MD, Michael Metro, MD, and other Fox Chase-Temple Urologic Institute Providers present a 53-year-old patient diagnosed with bilateral ureteral strictures from tuberculosis who undergoes a bilateral ureteral reconstruction.
Christine Amoroso Coordinates Treatment-Optimizing, Dedicated Intravesical Clinic
Amoroso is part of the nurse-led dedicated intravesical clinic that helps optimize treatment for patients and workflow for other physicians and nurses.
New Prognostic Model More Accurately Predicts Kidney Cancer Recurrence and Survival
Researchers at Fox Chase Cancer Center have developed a model that predicts disease recurrence and survival in patients with intermediate- and high-risk localized kidney cancer more accurately than existing prognostic models.
Kutikov Leads International Effort to Optimize Management of Adrenal Masses
Fox Chase’s Alexander Kutikov, MD, FACS, is leading an international effort to create a centralized, streamlined, point-of-care resource for the management of adrenal masses.
For some men who need a biopsy to test for prostate cancer, Fox Chase Cancer Center now offers an alternative approach that is safer, with significantly lower risks of infection, and potentially higher rate of tumor detection. This new ...
How to Perform Device-Free, Free-Handed Transperineal Prostate Biopsy
Fox Chase Cancer Center’s urologic oncology group shares an educational video that provides instruction on how to perform a device-free, free-handed transperineal prostate biopsy.
Urology Team Continues Focus on Improving Kidney Cancer Surgery Outcomes
Two new collaborative publications focus on treatment decisions for patients with renal masses.
Fox Chase Genitourinary Cancer Physicians Gain National Recognition
Three members of Fox Chase Cancer Center’s Genitourinary Cancer Program – Elizabeth Plimack, MD, MS; Alexander Kutikov, MD, FACS; and Benjamin Miron, MD -- have gained national recognition for their work advancing the care of patients ...
Clinical Nurse Manager, Rebecca Farrell, MSN, RN, Keeps Calm, Carries On Amidst COVID-19 Pandemic
As patient care adapted to the restrictions of the COVID-19 pandemic, Farrell continued to ensure that patients had access to cutting-edge care.
Two Studies Provide Answers on Best Approach to Bladder Cancer Treatment
Evaluating the current standards of care for cystectomy yielded interesting results on when it is most appropriate.
Fox Chase Offers Ureteral Mitomycin Gel for Low-Grade Upper Tract Urothelial Carcinoma
Jelmyto provides an alternative treatment option for low-grade UTUC and may spare some patients from nephrectomy. A recent study of the treatment showed a 58% complete response rate.
Genitourinary Malignancies in the Time of COVID-19
The COVID-19 pandemic has precipitated many changes in medical practice. View this symposium, where the Fox Chase Cancer Center genitourinary (GU) oncology team will discuss the impact of the pandemic on GU cancer care as well as the latest ...
Robotic Complications and Management (Wisconsin Urological Society Annual Meeting)
Daniel Eun, MD, Fox Chase-Temple Urologic Institute Provider, discusses the management of complications in robot-assisted surgery.
Daniel Eun, MD and other Fox Chase-Temple Urologic Institiute Providers present a 72-year-old patient diagnosed with a left-sided distal ureteral stricture who undergoes a ureteral reimplantation.
Daniel Eun, MD, Fox Chase-Temple Urologic Institute Provider, discusses strategies for enabling complex robotic reconstruction of the upper urinary tract.
Michael J. Metro, MD, Fox Chase-Temple Urologic Institute Provider, discusses the importance of proper diagnosis for urethral stricutres.
Robotic Retzius Sparing Simple Prostatectomy with Anastomotic Reconstruction
Daniel Eun, MD, Fox Chase-Temple Urologic Institute Provider, discusses the advantages and disadvantages of Robotic Retzius Sparing Simple Prostatectomy when compared to Holmium Laser Enucleation of the Prostate (HoLEP)
Robotic Repair of Ureterovaginal Fistula using Indocyanine Green and Cosmetic Approach
Daniel D. Eun, MD, Michael J. Metro, MD and other providers from the Fox Chase-Temple Urologic Institiute present a 38-year-old patient diagnosed with an iatrogenic bladder injury who undergoes a Ureterovaginal Fistual repair.
Urethroplasty Therapeutic Options
Michael J. Metro, MD, Fox Chase-Temple Urologic Institute Provider, discusses therapeutic and reconstructive surgery options for the treatment of strictures.
Pioneering Surgical Techniques with Advanced Robotic Surgery
Temple robotic surgeons are making it possible for more patients to receive lifesaving therapies after being told they were out of options.
Fox Chase Offering Prostate Micro-Ultrasound Technology
Fox Chase Cancer Center is now offering patients a more convenient and effective method of prostate cancer diagnosis—the ExactVu™ micro-ultrasound system.
Urologic Oncology APP and MD Author Book Chapter on Kidney Cancer
The clinicians in Fox Chase Cancer Center’s Division of Urology and Urologic Oncology are accustomed to providing patients with specialized care and advanced treatment, but they are also dedicated to sharing their experience and educating ...
Surgeon, Mother, Pioneer: Surgical Oncologist Rosalia Viterbo, MD, Is Committed to It All
Viterbo brought her experience and expertise back to her practice at Fox Chase and, in the years since, has worked with colleagues in the Division of Urology and Urologic Oncology to pioneer the use of robotics in more and more cancer surgeries.
Meet Susan Sippel, Nursing Assistant in Fox Chase’s Urologic Oncology
Throughout Susan Sippel’s career at Fox Chase, three things have stood out: mentors, connecting with patients, and teamwork. She joined Fox Chase 29 years ago as a ward secretary for the Three South unit after her sister-in-law, a Fox ...
New research from clinical investigators at Fox Chase may help men with prostate cancer in selecting the appropriate type of radiation therapy to treat their disease.
Research Identifies Predictors of Concern in Post-Treatment Prostate Cancer Patients
In a recent study, Fox Chase Cancer Center researchers sought to identify predictors of concern in men who recently underwent treatment for prostate cancer.
Experience and Expertise Makes Retroperitoneal Approach an Option for Renal Surgery
Robot-assisted renal surgery using retroperitoneal access requires substantial technical expertise and experience, and the urologic oncology team at Fox Chase Cancer Center is one of few local centers of excellence that offers it as a treatment option.
International Collaborations Help Optimize Partial Nephrectomy Techniques
The urologic oncology team at Fox Chase Cancer Center continues to foster important international relationships in its pursuit of optimal surgical strategies for kidney cancer.
Identification and Management of Immunotherapy Toxicities
The NCCN and ASCO have developed new guidelines that describe which bodily systems can be affected by immunotherapy and how to manage side effects based on their severity.
Benjamin T. Ristau, MD, MHA, Randall A. Lee, MD, and Alexander Kutikov, MD, FACS, present a retroperitoneoscopic robot-assisted partial nephrectomy on a morbidly obese patient.
Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care
Over the last decade, dozens of predictive models have been developed to improve on the ability of stage, grade and type to predict recurrence. Unfortunately, many of the prediction models used by clinicians to guide patient care and clinical ...
De-escalating Treatment for Bladder and Prostate Cancers
Treatment approaches for bladder and prostate cancers have undergone rapid evolution in the last few years. Some patients can now safely delay or avoid surgery entirely and preserve their quality of life with positive oncological outcomes. ...
SpaceOAR Hydrogel Reduces Side Effects of Prostate Cancer Radiation Therapy
In a minimally invasive outpatient procedure, the two liquid components of SpaceOAR hydrogel are injected through the peritoneum (transperineally) into the space between the rectal wall and the prostate by a urologist. The procedure is ...
Clinical Connections - Hypofractionation
Using hypofractionation, or hypofractionated radiation therapy, more radiation dose is delivered per treatment, so patients can complete their course of radiation therapy much faster than conventional treatment.